Jim Cramer unpacks Tuesday's 'countertrend' market rally
"If this countertrend rally continues, so many stocks that sat out the first half will keep running, while this year's big winners go through a temporary cooling off period," he said.
While the S&P 500 dipped 0.11% and the tech-heavy Nasdaq Composite lost 0.82%, the Dow Jones Industrial Average gained 0.91%.
According to Cramer, some of this action came as a result of President Donald Trump's tax and spending bill, which could bode well for the housing market. The Senate passed the megabill on Tuesday. However, it is now headed back to the House, where it is certain to face scrutiny. A number of GOP lawmakers are wary of the bill because of its potential to increase the U.S.'s deficit, which is already substantial.
Cramer said the bill's victory in the Senate helped propel housing stocks, certain retailers and banks. But some of the rally was "nothing more than the left behind stocks playing catch-up," saying drug stocks, for example, "had a rare day in the sun."
He picked out a few stocks in these reinvigorated sectors that he feels are "best of breed" in their industries. For housing, he pinpointed Toll Brothers, saying the high-end homebuilder put up a solid quarter, and it might be poised to do well if wealthier consumers receive tax breaks. He said he liked retailers Home Depot and Kontoor Brands, which owns Wrangler and Lee jeans. According to Cramer, Home Depot usually works in the long term, praising the retailer's ability to reinvent itself. He said he's positive on Kontoor Brands in part because of its recent acquisition of Helly Hansen, an outdoor gear brand.
Cramer also said there are a number of winners from the first half of the year that are likely to finish out the year much higher, such as GE Vernova, Palantir and Howmet. He told investors to let these stocks cool off and return to them "when the rotation has run its course." However, he said Palantir has taken a "rare dip" and can be bought as soon as Monday.
"You are witnessing, or, I hope, participating in, one of the most equal opportunity bull markets I have ever seen," Cramer said.
Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter.Disclaimer The CNBC Investing Club holds shares of Home Depot and GE Vernova.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Trump wins again as ‘big beautiful bill' passes the Senate. What are the lessons for the Democrats?
Donald Trump is continuing his run of political wins after his keynote legislation, nicknamed the 'big beautiful bill', squeaked through the Senate. While the bill, which includes major cuts in tax and government spending, must now go back to the House of Representatives for another vote, passing the upper house is highly significant. Trump lost the support of just three Republican senators, and with the help of a tie-breaking vote from Vice-President J.D. Vance managed to push the bill forward. Democrats, the minority in both the House and Senate, have been unable to do anything but sit by and watch as Trump claims victory after victory. These include progress in his attempt to end birthright citizenship, the claimed destruction of significant Iranian nuclear sites (yet to be independently verified) and the convincing of Nato member states to increase defence spending to 5% of their GDP. Trump may even be getting closer to a peace deal between Israel and Hamas. And now the Democrats have failed in their desperate attempts to stop this bill. In the Senate, it was felt that there could be enough Republican senators concerned about cuts to Medicaid (the US system that provides essential healthcare to those on low incomes), the closure or reduction of services at rural hospitals, and the increase in national debt to potentially hinder the bill's progress. However, Democrats were unable to do anything apart from delaying the voting process, and the bill is progressing with some changes but not enough to be severely weakened. It had seemed likely that the Democrats could work with the Maga-focused Freedom Caucus group of representatives, whose members include Marjorie Taylor Greene, in the early stages in the House to stop its initial passage. But Speaker Mike Johnson managed to calm most of their fears about the rise in the deficit to get the bill through the House. The lack of effective opposition from the Democrats reflects their congressional standing. The Republicans control the Senate 53-47, and they also have a majority of 220-212 in the House, with three vacancies. While Democrat numbers in Congress is the primary issue in opposing this bill, their future congressional power will rely on strong leadership within the party and, more importantly, a clear set of policies with appeal that can attract more support at the ballot boxes. Failure to address this will probably allow Republicans to dominate Congress and shape American domestic and foreign policy any way they wish for longer. While Democrat Hakeem Jeffries has been a diligent minority leader in the House, he has attempted to operate as an obstacle to Republican policies with little success, rather than reaching across the political divide to create a consensus with dissenting Republicans. Outside of Congress, California governor Gavin Newsom, widely touted as a potential candidate for the next presidential election, has offered some resistance to the Trump administration, particularly over Trump's assumption of national command over the state-controlled National Guard to deal with protests in California against the Immigration and Customs Enforcement agency. However, Newsom's reputation is still relatively regional, although it is on the rise. There will be jostling over the next couple of years for the Democratic presidential nomination, and this will have an impact on the platform that the party runs on. Party members and those voting for the next presidential nominee will need to decide whether to continue with the mainly centrist position that the party has adopted since the 1990s or adopt something more left-wing. A more radical candidate, such as New York representative Alexandria Ocasio-Cortez, might offer a substantially different proposal that could seem attractive to Democratic voters and those Trump supporters who may feel dissatisfied with the current Republican administration. However, democratic socialist Zohran Mamdani, recently selected as the Democratic nominee for the New York mayoral election, has already been vilified by some in the Republican party. Concerns about such a supposedly 'radical' candidate may concern many voters in red states in middle America. However, getting elected is one thing but implementing progressive, left-leaning policies is another thing entirely. They also need to deliver solutions to major issues, such as crime, at all levels, to show their abilities to solve problems. It is not just the policies that matter for the Democrats, but who they want to represent. Last year's election suggested that the Democrats had been ousted as the representatives of the working class. Some significant labour unions, a foundation of Democratic support for the majority of the 20th century, failed to endorse Kamala Harris. Mamdani's success in New York stemmed from the mobilisation of a grassroots campaign that used social media effectively. It targeted young working-class voters disenchanted with the Democratic party. He also resonated with voters in areas that had seen an increase in Republican voters in the 2024 election. All this may offer some lessons to the Democrats. They need to reassess their policies, their image and their tactics, and show Americans that they can solve the problems that the public sees as most important, including the high cost of living. While they can expect to gain seats in the House in next year's midterms, they need to look for a leader and policies that will capture the public's hearts. This article is republished from The Conversation under a Creative Commons license. Read the original article. Dafydd Townley does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Yahoo
30 minutes ago
- Yahoo
Jim Cramer on TG Therapeutics: 'You Should Buy the Stock'
TG Therapeutics, Inc. (NASDAQ:TGTX) is one of the 14 stocks Jim Cramer recently looked at. When a caller inquired about the company during the lightning round, Cramer stated: 'I remember when Mike Weiss was an analyst. I always loved the man. I love him now. I think you should buy the stock.' A scientific researcher holding a petri dish containing a glycoengineered monoclonal antibody. TG Therapeutics, Inc. (NASDAQ:TGTX) develops and commercializes therapies for B-cell mediated diseases, and it offers BRIUMVI for multiple sclerosis and is advancing a pipeline of monoclonal antibodies and kinase inhibitors targeting autoimmune conditions and blood cancers. ClearBridge Investments stated the following regarding TG Therapeutics, Inc. (NASDAQ:TGTX) in its Q4 2024 investor letter: '2024 proved a particularly active year for new idea generation: we added 23 new investments while exiting 29 due to a variety of considerations, including acquisitions, market capitalization constraints, and our assessment of forward return potential. While many of the new investments we made during the year are of relatively modest size, we will continue to build these positions over time provided company execution and end market prospects remain intact. In the fourth quarter we initiated five new investments: Oscar Health,TG Therapeutics, Inc. (NASDAQ:TGTX), Clearwater Analytics, Fluor and Modine. While we acknowledge the potential of TGTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
30 minutes ago
- Yahoo
Jim Cramer Says 'CoreWeave is Too High'
CoreWeave, Inc. (NASDAQ:CRWV) is one of the 14 stocks Jim Cramer recently looked at. During the episode, Cramer mentioned that the stock has a lot of short sellers, as he commented: 'They think they may have another CoreWeave on their hands, that's a data center play that has 361 million shares, only 46 million are free to trade. When there are so few shares, it's very easy for buyers to annihilate the short sellers who bet against these stocks, and there are plenty of short sellers here. Considerable short, for instance, in CoreWeave, 31% of the float. That's kind of reminiscent of the old GameStop in a meme stock heyday… A portfolio manager analyzing a stock chart, seeking to find the right investments. CoreWeave (NASDAQ:CRWV) provides cloud infrastructure tailored for generative AI and offers compute, storage, networking, and managed services to support enterprise workloads. Additionally, the company delivers tools for AI training, rendering, and machine learning optimization. While we acknowledge the potential of CRWV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
